En undersøgelse til at undersøge effektiviteten og sikkerheden af Tezepelumab hos voksne deltagere med moderat til meget alvorlig KOL (D5241C00007) (JOURNEY)
En randomiseret, dobbeltblind, placebokontrolleret, parallel gruppe, multicentre, fase III-undersøgelse for at evaluere effektiviteten og sikkerheden af tezepelumab hos voksne deltagere med moderat til meget alvorlig kronisk obstruktiv lungesygdom
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of tezepelumab in adults with moderate to very severe chronic obstructive pulmonary disease (COPD) receiving inhaled maintenance therapy and having had at least 2 moderate, or 1 severe, COPD exacerbations in the 12 months prior to Visit 1. Subjects will receive monthly subcutaneous injection of one of two different doses of tezepelumab, or placebo, with a maximum treatment duration of 76 weeks and a minimum of 52 weeks. The study also includes a off-treatment safety follow-up period of 12 weeks.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: AstraZeneca Clinical Study Information Center
- Telefonnummer: 1-877-240-9479
- E-mail: information.center@astrazeneca.com
Studiesteder
-
-
-
Alberdi, Argentina, X5033DCE
- Rekruttering
- Research Site
-
Buenos Aires, Argentina, C1425BEN
- Rekruttering
- Research Site
-
Ciudad de Buenos Aires, Argentina, C1414AIF
- Rekruttering
- Research Site
-
Florida, Argentina, B1602DQD
- Rekruttering
- Research Site
-
La Plata, Argentina, B1904
- Rekruttering
- Research Site
-
La Plata, Argentina, B1900
- Rekruttering
- Research Site
-
Mar del Plata, Argentina, 7600
- Rekruttering
- Research Site
-
Mendoza, Argentina, M5500CCG
- Rekruttering
- Research Site
-
Quilmes, Argentina, B1878FNR
- Rekruttering
- Research Site
-
Rosario, Argentina, 2000
- Rekruttering
- Research Site
-
San Fernando, Argentina, B1646EBJ
- Rekruttering
- Research Site
-
San Juan Bautista, Argentina, 1888
- Rekruttering
- Research Site
-
-
-
-
-
Coffs Harbour, Australien, 02450
- Rekruttering
- Research Site
-
Frankston, Australien, 3199
- Rekruttering
- Research Site
-
Garran, Australien, 2605
- Trukket tilbage
- Research Site
-
Nedlands, Australien, 6009
- Rekruttering
- Research Site
-
New Lambton, Australien, 2310
- Afsluttet
- Research Site
-
Spearwood, Australien, 6163
- Rekruttering
- Research Site
-
Wollongong, Australien, 2500
- Trukket tilbage
- Research Site
-
Woodville South, Australien, 5011
- Afsluttet
- Research Site
-
-
-
-
-
Genk, Belgien, 3600
- Rekruttering
- Research Site
-
Ghent, Belgien, 9000
- Rekruttering
- Research Site
-
Jette, Belgien, 1090
- Rekruttering
- Research Site
-
Leuven, Belgien, 3000
- Rekruttering
- Research Site
-
Mechelen, Belgien, 2800
- Rekruttering
- Research Site
-
Namur, Belgien, 5101
- Rekruttering
- Research Site
-
-
-
-
-
Dupnitsa, Bulgarien, 2600
- Rekruttering
- Research Site
-
Haskovo, Bulgarien, 6300
- Rekruttering
- Research Site
-
Lovech, Bulgarien, 5500
- Trukket tilbage
- Research Site
-
Pleven, Bulgarien, 5800
- Rekruttering
- Research Site
-
Plovdiv, Bulgarien, 4003
- Rekruttering
- Research Site
-
Rousse, Bulgarien, 7000
- Trukket tilbage
- Research Site
-
Rousse, Bulgarien, 7000
- Rekruttering
- Research Site
-
Sofia, Bulgarien, 1000
- Rekruttering
- Research Site
-
Sofia, Bulgarien, 1431
- Rekruttering
- Research Site
-
Sofia, Bulgarien, 1756
- Rekruttering
- Research Site
-
Sofia, Bulgarien, 1202
- Trukket tilbage
- Research Site
-
Stara Zagora, Bulgarien, 6003
- Rekruttering
- Research Site
-
Varna, Bulgarien, 9000
- Trukket tilbage
- Research Site
-
Veliko Tanovo, Bulgarien, 5000
- Rekruttering
- Research Site
-
Veliko Tarnovo, Bulgarien, 5000
- Rekruttering
- Research Site
-
Vidin, Bulgarien, 3700
- Rekruttering
- Research Site
-
Yambol, Bulgarien, 8600
- Rekruttering
- Research Site
-
-
-
-
-
Armenia, Colombia, 630004
- Rekruttering
- Research Site
-
Barranquilla, Colombia, 080020
- Rekruttering
- Research Site
-
Bogotá, Colombia, 110131
- Rekruttering
- Research Site
-
Cali, Colombia, 760042
- Rekruttering
- Research Site
-
Ibague, Colombia, 730006
- Rekruttering
- Research Site
-
Manizales, Colombia, 170004
- Rekruttering
- Research Site
-
Medellín, Colombia, 050030
- Rekruttering
- Research Site
-
Medellín, Colombia, 050022
- Rekruttering
- Research Site
-
-
-
-
-
Aalborg, Danmark, 9000
- Rekruttering
- Research Site
-
Hvidovre, Danmark, 2650
- Rekruttering
- Research Site
-
Næstved, Danmark, 4700
- Rekruttering
- Research Site
-
Odense C, Danmark, 5000
- Rekruttering
- Research Site
-
Vejle, Danmark, 7100
- Rekruttering
- Research Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35205
- Ikke rekrutterer endnu
- Research Site
-
Cullman, Alabama, Forenede Stater, 35055
- Rekruttering
- Research Site
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85044
- Rekruttering
- Research Site
-
Scottsdale, Arizona, Forenede Stater, 85258
- Rekruttering
- Research Site
-
-
California
-
Inglewood, California, Forenede Stater, 90301
- Trukket tilbage
- Research Site
-
Los Angeles, California, Forenede Stater, 90048
- Suspenderet
- Research Site
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- Research Site
-
Redding, California, Forenede Stater, 96001
- Rekruttering
- Research Site
-
San Diego, California, Forenede Stater, 92108
- Suspenderet
- Research Site
-
-
Connecticut
-
New Britain, Connecticut, Forenede Stater, 06051
- Rekruttering
- Research Site
-
-
Delaware
-
Wilmington, Delaware, Forenede Stater, 19803
- Rekruttering
- Research Site
-
-
Florida
-
Bay Pines, Florida, Forenede Stater, 33744
- Rekruttering
- Research Site
-
Boynton Beach, Florida, Forenede Stater, 33435
- Rekruttering
- Research Site
-
Cape Coral, Florida, Forenede Stater, 33990
- Ikke rekrutterer endnu
- Research Site
-
Clearwater, Florida, Forenede Stater, 33765
- Afsluttet
- Research Site
-
Fleming Island, Florida, Forenede Stater, 32003
- Suspenderet
- Research Site
-
Jacksonville, Florida, Forenede Stater, 32209
- Rekruttering
- Research Site
-
Leesburg, Florida, Forenede Stater, 34748
- Rekruttering
- Research Site
-
Margate, Florida, Forenede Stater, 33063
- Trukket tilbage
- Research Site
-
Miami, Florida, Forenede Stater, 33126
- Rekruttering
- Research Site
-
Miami, Florida, Forenede Stater, 33155
- Suspenderet
- Research Site
-
Miami Lakes, Florida, Forenede Stater, 33014
- Suspenderet
- Research Site
-
Ocala, Florida, Forenede Stater, 34470
- Rekruttering
- Research Site
-
Palmetto Bay, Florida, Forenede Stater, 33157
- Suspenderet
- Research Site
-
Winter Park, Florida, Forenede Stater, 32789
- Rekruttering
- Research Site
-
-
Georgia
-
Adairsville, Georgia, Forenede Stater, 30103
- Suspenderet
- Research Site
-
Atlanta, Georgia, Forenede Stater, 30349
- Rekruttering
- Research Site
-
Cordele, Georgia, Forenede Stater, 31015
- Rekruttering
- Research Site
-
Decatur, Georgia, Forenede Stater, 30033
- Rekruttering
- Research Site
-
Fort Gordon, Georgia, Forenede Stater, 30905
- Trukket tilbage
- Research Site
-
Savannah, Georgia, Forenede Stater, 31406
- Rekruttering
- Research Site
-
-
Illinois
-
Evanston, Illinois, Forenede Stater, 60201
- Rekruttering
- Research Site
-
Hinsdale, Illinois, Forenede Stater, 60521
- Ikke rekrutterer endnu
- Research Site
-
Springfield, Illinois, Forenede Stater, 62703
- Ikke rekrutterer endnu
- Research Site
-
-
Indiana
-
Evansville, Indiana, Forenede Stater, 47725
- Rekruttering
- Research Site
-
Indianapolis, Indiana, Forenede Stater, 46202
- Rekruttering
- Research Site
-
Indianapolis, Indiana, Forenede Stater, 46268
- Rekruttering
- Research Site
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66160
- Rekruttering
- Research Site
-
-
Kentucky
-
Bowling Green, Kentucky, Forenede Stater, 42101
- Rekruttering
- Research Site
-
Owensboro, Kentucky, Forenede Stater, 42301
- Rekruttering
- Research Site
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21224
- Rekruttering
- Research Site
-
Bethesda, Maryland, Forenede Stater, 20889
- Ikke rekrutterer endnu
- Research Site
-
Potomac, Maryland, Forenede Stater, 20854
- Rekruttering
- Research Site
-
Rosedale, Maryland, Forenede Stater, 21237
- Suspenderet
- Research Site
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48109
- Rekruttering
- Research Site
-
-
Minnesota
-
Minneapolis, Minnesota, Forenede Stater, 55425
- Rekruttering
- Research Site
-
-
Missouri
-
Hannibal, Missouri, Forenede Stater, 63401
- Rekruttering
- Research Site
-
-
New York
-
Staten Island, New York, Forenede Stater, 10309
- Rekruttering
- Research Site
-
Syracuse, New York, Forenede Stater, 13203
- Rekruttering
- Research Site
-
The Bronx, New York, Forenede Stater, 10459
- Rekruttering
- Research Site
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28277
- Rekruttering
- Research Site
-
Concord, North Carolina, Forenede Stater, 28025
- Rekruttering
- Research Site
-
Fayetteville, North Carolina, Forenede Stater, 28303
- Trukket tilbage
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73102
- Rekruttering
- Research Site
-
Tulsa, Oklahoma, Forenede Stater, 74133
- Rekruttering
- Research Site
-
-
Oregon
-
Grants Pass, Oregon, Forenede Stater, 97527
- Trukket tilbage
- Research Site
-
-
Pennsylvania
-
Horsham, Pennsylvania, Forenede Stater, 19044
- Rekruttering
- Research Site
-
Pittsburgh, Pennsylvania, Forenede Stater, 15241
- Rekruttering
- Research Site
-
Sayre, Pennsylvania, Forenede Stater, 18840
- Rekruttering
- Research Site
-
-
South Carolina
-
Anderson, South Carolina, Forenede Stater, 29621
- Rekruttering
- Research Site
-
Columbia, South Carolina, Forenede Stater, 29204
- Rekruttering
- Research Site
-
Gaffney, South Carolina, Forenede Stater, 29340
- Rekruttering
- Research Site
-
Little River, South Carolina, Forenede Stater, 29566
- Ikke rekrutterer endnu
- Research Site
-
Spartanburg, South Carolina, Forenede Stater, 29303
- Rekruttering
- Research Site
-
Union, South Carolina, Forenede Stater, 29379
- Rekruttering
- Research Site
-
-
South Dakota
-
Rapid City, South Dakota, Forenede Stater, 57702
- Rekruttering
- Research Site
-
-
Tennessee
-
Hendersonville, Tennessee, Forenede Stater, 37075
- Ikke rekrutterer endnu
- Research Site
-
Knoxville, Tennessee, Forenede Stater, 37919
- Rekruttering
- Research Site
-
Lebanon, Tennessee, Forenede Stater, 37087
- Ikke rekrutterer endnu
- Research Site
-
-
Texas
-
Boerne, Texas, Forenede Stater, 78006
- Rekruttering
- Research Site
-
El Paso, Texas, Forenede Stater, 79902
- Rekruttering
- Research Site
-
Houston, Texas, Forenede Stater, 77074
- Rekruttering
- Research Site
-
Houston, Texas, Forenede Stater, 77094
- Rekruttering
- Research Site
-
Houston, Texas, Forenede Stater, 77008
- Rekruttering
- Research Site
-
Lewisville, Texas, Forenede Stater, 75067
- Rekruttering
- Research Site
-
McKinney, Texas, Forenede Stater, 75069
- Rekruttering
- Research Site
-
Mesquite, Texas, Forenede Stater, 75149
- Rekruttering
- Research Site
-
San Antonio, Texas, Forenede Stater, 78258
- Rekruttering
- Research Site
-
-
Vermont
-
Colchester, Vermont, Forenede Stater, 05446
- Rekruttering
- Research Site
-
-
Virginia
-
Williamsburg, Virginia, Forenede Stater, 23188
- Rekruttering
- Research Site
-
-
Washington
-
Everett, Washington, Forenede Stater, 98208
- Rekruttering
- Research Site
-
-
Wisconsin
-
Kenosha, Wisconsin, Forenede Stater, 53142
- Ikke rekrutterer endnu
- Research Site
-
-
-
-
-
Brest, Frankrig, 29609
- Rekruttering
- Research Site
-
Lyon, Frankrig, 69317
- Rekruttering
- Research Site
-
Marseille, Frankrig, 13915
- Rekruttering
- Research Site
-
Montpellier, Frankrig, 34295
- Rekruttering
- Research Site
-
Paris, Frankrig, 75014
- Rekruttering
- Research Site
-
Paris, Frankrig, 75877
- Rekruttering
- Research Site
-
Pessac, Frankrig, 33604
- Rekruttering
- Research Site
-
Saint-Herblain, Frankrig, 44800
- Rekruttering
- Research Site
-
-
-
-
-
Athens, Grækenland, 11527
- Rekruttering
- Research Site
-
Athens, Grækenland, 17562
- Rekruttering
- Research Site
-
Athens, Grækenland, 11521
- Rekruttering
- Research Site
-
Heraklion, Grækenland, 71110
- Rekruttering
- Research Site
-
Ioannina, Grækenland, 45500
- Rekruttering
- Research Site
-
Pátrai, Grækenland, 26332
- Rekruttering
- Research Site
-
Thessaloniki, Grækenland, 57010
- Rekruttering
- Research Site
-
Thessaloniki, Grækenland, 57001
- Rekruttering
- Research Site
-
-
-
-
-
Eindhoven, Holland, 5623 EJ
- Rekruttering
- Research Site
-
Maastricht, Holland, 6229 HX
- Rekruttering
- Research Site
-
Rotterdam, Holland, 3045 PM
- Rekruttering
- Research Site
-
Rotterdam, Holland, 3083 AN
- Rekruttering
- Research Site
-
Zutphen, Holland, 7207 AE
- Rekruttering
- Research Site
-
-
-
-
-
Hong Kong, Hong Kong, 999077
- Rekruttering
- Research Site
-
-
-
-
-
Ashkelon, Israel, 78278
- Rekruttering
- Research Site
-
Haifa, Israel, 34362
- Rekruttering
- Research Site
-
Jerusalem, Israel, 00000
- Rekruttering
- Research Site
-
Jerusalem, Israel, 90131
- Rekruttering
- Research Site
-
Kfar Saba, Israel, 4428164
- Rekruttering
- Research Site
-
Ramat Gan, Israel, 52621
- Rekruttering
- Research Site
-
Rehovot, Israel, 76100
- Rekruttering
- Research Site
-
Tel Aviv, Israel, 6423906
- Rekruttering
- Research Site
-
-
-
-
-
Akashi-shi, Japan, 674-0063
- Rekruttering
- Research Site
-
Chikushino-shi, Japan, 818-8502
- Rekruttering
- Research Site
-
Chiyoda-ku, Japan, 1020074
- Rekruttering
- Research Site
-
Fukui-shi, Japan, 910-8526
- Rekruttering
- Research Site
-
Fukuoka, Japan, 811-1394
- Rekruttering
- Research Site
-
Fukuoka, Japan, 819-8555
- Rekruttering
- Research Site
-
Gifu, Japan, 502-8558
- Rekruttering
- Research Site
-
Iruma-Gun, Japan, 350-0495
- Rekruttering
- Research Site
-
Ishinomaki, Japan, 986-8522
- Rekruttering
- Research Site
-
Kasuga-shi, Japan, 816-0864
- Rekruttering
- Research Site
-
Kitakyushu-shi, Japan, 807-8555
- Rekruttering
- Research Site
-
Kiyose-shi, Japan, 204-8585
- Rekruttering
- Research Site
-
Kiyose-shi, Japan, 204-8522
- Rekruttering
- Research Site
-
Kobe, Japan, 650-0047
- Rekruttering
- Research Site
-
Komatsu-shi, Japan, 923-8560
- Rekruttering
- Research Site
-
Kure-shi, Japan, 737-8505
- Rekruttering
- Research Site
-
Kyoto, Japan, 612-8555
- Rekruttering
- Research Site
-
Matsusaka-shi, Japan, 515-8544
- Rekruttering
- Research Site
-
Meguro-ku, Japan, 153-0051
- Trukket tilbage
- Research Site
-
Minatoku, Japan, 108-0073
- Rekruttering
- Research Site
-
Minatoku, Japan, 105-8470
- Rekruttering
- Research Site
-
Miyazaki, Japan, 889-1692
- Rekruttering
- Research Site
-
Mizunami-shi, Japan, 509-6134
- Rekruttering
- Research Site
-
Nagaoka-shi, Japan, 940-8621
- Rekruttering
- Research Site
-
Nagasaki, Japan, 852-8501
- Rekruttering
- Research Site
-
Nagoya, Japan, 466-8650
- Rekruttering
- Research Site
-
Nagoya, Japan, 457-0866
- Rekruttering
- Research Site
-
Nagoya, Japan, 457-8511
- Rekruttering
- Research Site
-
Nerima-ku, Japan, 177-8521
- Rekruttering
- Research Site
-
Ohta-ku, Japan, 143-0013
- Trukket tilbage
- Research Site
-
Okayama, Japan, 700-8558
- Rekruttering
- Research Site
-
Okayama, Japan, 701-1192
- Rekruttering
- Research Site
-
Osaka, Japan, 540-0008
- Rekruttering
- Research Site
-
Sapporo, Japan, 064-0804
- Rekruttering
- Research Site
-
Sendai, Japan, 980-8574
- Rekruttering
- Research Site
-
Sendai, Japan, 983-8520
- Rekruttering
- Research Site
-
Shinjuku-ku, Japan, 160-8582
- Rekruttering
- Research Site
-
Shinjuku-ku, Japan, 162-8655
- Rekruttering
- Research Site
-
Shinjuku-ku, Japan, 162-8666
- Rekruttering
- Research Site
-
Shiogama, Japan, 985-8506
- Rekruttering
- Research Site
-
Takamatsu, Japan, 760-0018
- Rekruttering
- Research Site
-
Takatsuiki-shi, Japan, 569-1096
- Trukket tilbage
- Research Site
-
Tanabe-shi, Japan, 646-8558
- Rekruttering
- Research Site
-
Toshima-ku, Japan, 171-0014
- Trukket tilbage
- Research Site
-
Ube, Japan, 755-8505
- Rekruttering
- Research Site
-
Yokohama, Japan, 236-0004
- Rekruttering
- Research Site
-
Yokohama, Japan, 245-8575
- Trukket tilbage
- Research Site
-
-
-
-
-
Auckland, New Zealand, 2025
- Rekruttering
- Research Site
-
Auckland, New Zealand, 1051
- Rekruttering
- Research Site
-
Auckland, New Zealand, 0626
- Afsluttet
- Research Site
-
Hamilton West, New Zealand, 3204
- Rekruttering
- Research Site
-
Tauranga, New Zealand, 3112
- Rekruttering
- Research Site
-
-
-
-
-
Callao, Peru, Bellavista
- Rekruttering
- Research Site
-
Cusco, Peru, CUSCO 01
- Trukket tilbage
- Research Site
-
Lima, Peru, 15036
- Rekruttering
- Research Site
-
Lima, Peru, 15088
- Rekruttering
- Research Site
-
Lima, Peru, 15046
- Rekruttering
- Research Site
-
Lima, Peru, 15036
- Trukket tilbage
- Research Site
-
Lima, Peru, 15038
- Trukket tilbage
- Research Site
-
Lima, Peru, 15023
- Rekruttering
- Research Site
-
Lima, Peru, LIMA 1
- Rekruttering
- Research Site
-
Lima, Peru, 15131
- Rekruttering
- Research Site
-
Lima, Peru, LIMA 21
- Trukket tilbage
- Research Site
-
Lima, Peru, LIMA 33
- Trukket tilbage
- Research Site
-
Lima, Peru, LIMA 01
- Suspenderet
- Research Site
-
Piura, Peru, 20001
- Rekruttering
- Research Site
-
-
-
-
-
Bucharest, Rumænien, 012363
- Rekruttering
- Research Site
-
Bucharest, Rumænien, 011461
- Trukket tilbage
- Research Site
-
Bucharest, Rumænien, 030167
- Rekruttering
- Research Site
-
Cluj-Napoca, Rumænien, 400332
- Rekruttering
- Research Site
-
Cluj-Napoca, Rumænien, 400275
- Suspenderet
- Research Site
-
Oradea, Rumænien, 410176
- Rekruttering
- Research Site
-
Timișoara, Rumænien, 300310
- Rekruttering
- Research Site
-
Timișoara, Rumænien, 300002
- Suspenderet
- Research Site
-
-
-
-
-
Gothenburg, Sverige, 413 46
- Rekruttering
- Research Site
-
Karlskrona, Sverige, 371 79
- Rekruttering
- Research Site
-
Lund, Sverige, 22185
- Rekruttering
- Research Site
-
Stockholm, Sverige, 171 64
- Rekruttering
- Research Site
-
Stockholm, Sverige, 11446
- Rekruttering
- Research Site
-
Örebro, Sverige, 703 62
- Rekruttering
- Research Site
-
-
-
-
-
Bellville, Sydafrika, 7530
- Rekruttering
- Research Site
-
Benoni, Sydafrika, 1501
- Rekruttering
- Research Site
-
Cape Town, Sydafrika, 7700
- Rekruttering
- Research Site
-
Durban, Sydafrika, 4001
- Rekruttering
- Research Site
-
Durban, Sydafrika, 4093
- Rekruttering
- Research Site
-
Kimberley, Sydafrika, 8301
- Trukket tilbage
- Research Site
-
Somerset West, Sydafrika, 7130
- Rekruttering
- Research Site
-
eMkhomazi, Sydafrika, 4170
- Rekruttering
- Research Site
-
-
-
-
-
Bangkok, Thailand, 10330
- Rekruttering
- Research Site
-
Hat Yai, Thailand, 90110
- Rekruttering
- Research Site
-
Muang, Thailand, 22000
- Rekruttering
- Research Site
-
Muang, Thailand, 40002
- Rekruttering
- Research Site
-
Mueang, Thailand, 20000
- Rekruttering
- Research Site
-
Nonthaburi, Thailand, 11000
- Rekruttering
- Research Site
-
Rayong, Thailand, 21000
- Rekruttering
- Research Site
-
-
-
-
-
Adana, Tyrkiet (Türkiye), 1330
- Rekruttering
- Research Site
-
Ankara, Tyrkiet (Türkiye), 6620
- Rekruttering
- Research Site
-
Istanbul, Tyrkiet (Türkiye), 34020
- Rekruttering
- Research Site
-
Kayseri, Tyrkiet (Türkiye), 38039
- Rekruttering
- Research Site
-
Kocaeli, Tyrkiet (Türkiye), 41380
- Rekruttering
- Research Site
-
Mersin, Tyrkiet (Türkiye), 33079
- Rekruttering
- Research Site
-
-
-
-
-
Budapest, Ungarn, 1036
- Rekruttering
- Research Site
-
Debrecen, Ungarn, 4032
- Rekruttering
- Research Site
-
Edelény, Ungarn, 3780
- Rekruttering
- Research Site
-
Gödöllő, Ungarn, 2100
- Rekruttering
- Research Site
-
Hatvan, Ungarn, 3000
- Rekruttering
- Research Site
-
Mosonmagyaróvár, Ungarn, 9200
- Rekruttering
- Research Site
-
Nyíregyháza-Sóstóhegy, Ungarn, 4481
- Rekruttering
- Research Site
-
Törökbálint, Ungarn, 2045
- Rekruttering
- Research Site
-
-
-
-
-
Can Tho, Vietnam, 900000
- Trukket tilbage
- Research Site
-
Da Nang, Vietnam, 550000
- Rekruttering
- Research Site
-
Haiphong, Vietnam, 180000
- Rekruttering
- Research Site
-
Hanoi, Vietnam, 100000
- Rekruttering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Rekruttering
- Research Site
-
Ho Chi Minh City, Vietnam
- Rekruttering
- Research Site
-
Huế, Vietnam, 530000
- Rekruttering
- Research Site
-
Hồ Chí Minh, Vietnam, 700000
- Rekruttering
- Research Site
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- ≥40 to ≤80 years old
- COPD diagnosis ≥1 year,
- Post-BD FEV1 ≥ 20% and ≤ 70% PN, FEV1/FVC <0.70 at screening
- Triple (ICS+LABA+LAMA) or dual inhaled COPD therapy, if triple therapy is considered not appropriate, ≥3 consecutive months prior to V1
- ≥2 moderate or ≥1 severe COPD exacerbations in the prior year; At least 1 of 2 moderate exacerbations must require the use of systemic corticosteroids. At least one of the previous exacerbations should be confirmed to have occurred while the participant was on triple or dual inhaled maintenance therapy
- EOS ≥ 150 cells/μL during screening
- CAT ≥15 at screening
- Former or current smokers ≥10 pack-years
Exclusion Criteria:
-
Clin. important pulmonary disease or radiological findings suggestive of a respiratory disease other than COPD
-
Asthma, incl. pediatric, or ACOS
-
Any unstable disorder that can impact participants safety or study outcomes
-
Tuberculosis requiring treatment within 12 months prior V2
-
Malignancies current or past
Concomitant therapies:
- Macrolides (less than 6 months)
- Systemic immuno-suppressive, -modulating medications
-
LTOT >4.0 L/min or O2 saturation <89% despite LTOT
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Dose 1 of Tezepelumab
Tezepelumab, SC, Q4W |
Tezepelumab subcutaneous injection |
|
Eksperimentel: Dose 2 of Tezepelumab
Tezepelumab, SC, Q4W |
Tezepelumab subcutaneous injection |
|
Placebo komparator: Matching Placebo
Matching placebo, SC, Q4W |
Placebo subcutaneous injection |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Annualised rate of moderate or severe COPD exacerbations
Tidsramme: Baseline up to 76 weeks
|
The annualised moderate or severe COPD exacerbation rate (based on exacerbations reported by the investigator) up to 76 weeks treatment period compared to placebo. |
Baseline up to 76 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in post-BD FEV1
Tidsramme: From baseline to Week 52
|
Change from baseline in post-BD FEV1 at Week 52 compared to placebo. FEV1 is defined as the volume of air exhaled from the lungs in the first second of a forced expiration |
From baseline to Week 52
|
|
Change from baseline in pre-dose/pre-bronchodilator (pre-BD) forced expiratory volume in 1 second (FEV1)
Tidsramme: From baseline to Week 52
|
Change from baseline in pre-BD FEV1 at Week 52 compared to placebo. FEV1 is defined as the volume of air exhaled from the lungs in the first second of a forced expiration |
From baseline to Week 52
|
|
Change from baseline in the St. George's Respiratory Questionnaire (SGRQ) total score
Tidsramme: From baseline over 52 weeks
|
Change from baseline in the SGRQ total score over 52 weeks compared to placebo. SGRQ is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Scores range from 0 to 100, with lower scores indicating better health status. |
From baseline over 52 weeks
|
|
Annualised rate of moderate or severe COPD exacerbations among participants with EOS ≥ 300 cells/µL collected during screening visit.
Tidsramme: Baseline up to 76 weeks
|
The annualised moderate or severe COPD exacerbation rate (based on exacerbations reported by the investigator) up to 76 weeks treatment period compared to placebo among participants with EOS ≥ 300 cells/µL collected during screening visit. |
Baseline up to 76 weeks
|
|
Annualised rate of severe COPD exacerbations
Tidsramme: Baseline up to 76 weeks
|
The annualised severe COPD exacerbation rate (based on exacerbations reported by the investigator) up to 76 weeks treatment period compared to placebo |
Baseline up to 76 weeks
|
|
Annualised rate of COPD exacerbations requiring ER visit and/or hospitalisation
Tidsramme: Baseline up to 76 Weeks
|
The annualised rate of COPD exacerbation requiring ER visit and/or hospitalisation up to 76 weeks treatment period compared to placebo. |
Baseline up to 76 Weeks
|
|
Clinical meaningful improvement in St. George's Respiratory Questionnaire (SGRQ) total score
Tidsramme: From baseline over 52 weeks
|
Participants achieving a clinically meaningful improvement from baseline in SGRQ total score (4-point score decrease) over 52 weeks. SGRQ is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Scores range from 0 to 100, with lower scores indicating better health status. |
From baseline over 52 weeks
|
|
Change from baseline in the COPD assessment Test (CAT) total score
Tidsramme: From baseline over 52 weeks
|
Change from baseline in the CAT total score over 52 weeks CAT is an 8-item PRO that measures the impact of COPD on the health status of patients with COPD. The CAT has a scoring range of 0-40 with higher scores indicative of greater COPD impact on health status. |
From baseline over 52 weeks
|
|
Clinical meaningful improvement in COPD Assessment Test (CAT) total score
Tidsramme: From baseline over 52 weeks
|
Participants achieving a clinically meaningful improvement from baseline in CAT total score (2-point score decrease) over 52 weeks. CAT is an 8-item PRO that measures the impact of COPD on the health status of patients with COPD. The CAT has a scoring range of 0-40 with higher scores indicative of greater COPD impact on health status. |
From baseline over 52 weeks
|
|
Time to first moderate or severe COPD exacerbation
Tidsramme: Baseline up to 76 weeks
|
Time to first occurrence of moderate or severe COPD exacerbation up to 76 weeks |
Baseline up to 76 weeks
|
|
Time to first severe COPD exacerbation
Tidsramme: Baseline up to 76 weeks
|
Time to first occurrence of severe COPD exacerbation up to 76 weeks |
Baseline up to 76 weeks
|
|
Pharmacokinetics (PK): Serum trough concentrations
Tidsramme: Baseline, Week 24, Week 36, Week 52
|
Serum trough concentrations |
Baseline, Week 24, Week 36, Week 52
|
|
Immunogenicity of anti-drug antibodies (ADA)
Tidsramme: Baseline, Week 24, Week 36, Week 52
|
Incidence of anti-drug antibodies |
Baseline, Week 24, Week 36, Week 52
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: MeiLan Han, MD, University of Michigan Health, Pulmonary & Critical Care Medicine,
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- D5241C00007
- 2024-517457-27-00 (Registry Identifier: CTIS (EU))
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment:
https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure
Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
IPD-delingstidsramme
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA/PhRMA Data-Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
IPD-delingsadgangskriterier
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .